AACE GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!
Adverse Effects
Contraindications
Frequent weight gain,
edema, increased risk
of CHF, especially in
patients on insulin.
Can reduce bone
mineralization. Associated
with nonosteoporotic
bone fractures.
Cautions:
Should not be used in
patients with CHF.
Hepatic impairment,
NYHA Class III
or IV CHF.
Comments
Flatulence and other GI
symptoms.
Less potent than other
agents.
Use with caution in
presence of GI disease.
GI adverse effects.
Nausea, dizziness.
19